EnWave Files nutraREV Patent

EnWave Corporation has received positive comments from the Patent Examiner with regard to its Patent Co-Operation Treaty patent application for nutraREV equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability is forthcoming. The PCT process allows inventors to obtain patent priority in more than 140 countries at the same time, thereby saving considerable time and deferring the cost of individual national filings for 30 months.

EnWave has now filed a Canadian national patent application for the nutraREV equipment with a request for expedited review in order to receive an issued patent as quickly as possible. The Company believes a Canadian patent on this technology will further reinforce its nutraREV marketing success which is already protected by six issued patents.

EnWave holds an expanding intellectual property portfolio designed to protect the technology and knowledge base of the company. In addition to patent filings on EnWave’s other Radiant Energy Vacuum dehydration processes and equipment, the Company holds an exclusive world-wide license from the University of British Columbia for a number of  food and biopharmaceutical dehydration patents which were invented at the UBC laboratory of EnWave’s founder and Co-CEO, Dr. Tim Durance. To-date, the Company has obtained the exclusive global rights to food-related patents for the dehydration of low-fat snack foods, potato pieces, krill, medicinal plants, fruit, and berries. The new patent would be the first one to directly protect the Company’s industrial-scale vacuum microwave food dehydration equipment.

EnWave expects that the Canadian patent will be reviewed over the next few months, and a decision announced in Q1, 2010. The Company will then proceed with further national filings to ensure protection in major markets throughout the world.

More News:

All news »

What are your comments?

You cannot post comments until you have logged in. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments